SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Eris Lifesciences executes agreement with Kinedex Healthcare

09 Nov 2018 Evaluate

Eris Lifesciences has executed a share purchase agreement with Rakesh Dhuria, a promoter of Kinedex Healthcare, with the intent of increasing its ownership and control of the said subsidiary i.e. Kinedex by way of purchase of 12,239 equity shares of face value of Rs 10 each (equivalent to 6.71%).

Prior to this transaction, the company (including its nominees) held 75.48% shareholding in Kinedex. Post completion of this transaction, the total holding of the company (including its Nominees) shall stand at 82.19% (rounded to two decimal places).

Eris Lifesciences is engaged in manufacturing, marketing and selling of branded generics within the chronic and acute categories of the Indian Pharmaceutical Market.

Eris Lifesciences Share Price

1446.50 -18.90 (-1.29%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×